Israel is home to more than 750 medical device companies, 300 pharmaceutical/biotech companies, and 170 other life science or healthcare IT companies. David Dykeman, co-chair of Greenberg Traurig’s Life Science & Medical Technology Group, describes Israel as a “biomedical and healthcare powerhouse.”
David recently led a delegation of New England executives and investors from the biomedical, healthcare and life science sectors to spend three days exploring Israeli innovation and commercialization, learning about Israel’s cutting edge medical technology and investment trends, and speaking with executives of Israeli companies. In return, Israeli executives learned more about why Boston – with its own tech innovation, renowned universities and venture capital investors – is a natural fit for Israeli companies looking to enter the U.S. market.
Continue Reading New England Executives Get an Inside Look at Israeli Innovation